![Matthew Rotenberg](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Matthew Rotenberg
Directeur/Bestuurslid bij Biosimilars Canada
Profiel
Matthew Rotenberg is currently a Director at Biosimilars Canada.
Prior to this, he was the Chief Executive Officer at Fresenius Kabi Canada Ltd.
from 2000 to 2023.
Actieve functies van Matthew Rotenberg
Bedrijven | Functie | Begin |
---|---|---|
Biosimilars Canada
![]() Biosimilars Canada Miscellaneous Commercial ServicesCommercial Services Biosimilars Canada is a division of the Canadian Generic Pharmaceutical Association that provides leadership in educating Canadian stakeholders about the safety and efficacy of biosimilar medicines. Biosimilars Canada is based in Toronto, Canada. The member companies of Biosimilars Canada are involved in the development and marketing of biosimilar medicines. The organization advocates for policies that support the timely approval, reimbursement, market acceptance, and expanded use of biosimilar medicines. Health Canada evaluates all the information provided to confirm that the biosimilar and the reference biologic drug are similar and that there are no clinically meaningful differences in safety and efficacy between them. | Directeur/Bestuurslid | - |
Eerdere bekende functies van Matthew Rotenberg
Bedrijven | Functie | Einde |
---|---|---|
Fresenius Kabi Canada Ltd.
![]() Fresenius Kabi Canada Ltd. Pharmaceuticals: MajorHealth Technology Fresenius Kabi Canada Ltd. health care services. The firm offers intravenous specialty and generic medicines, transfusion technologies, infusion therapies, parental nutrition, and medical devices. The company was founded in 1999 and is headquartered in Toronto, Canada. | Algemeen Directeur | 01-07-2023 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
Fresenius Kabi Canada Ltd.
![]() Fresenius Kabi Canada Ltd. Pharmaceuticals: MajorHealth Technology Fresenius Kabi Canada Ltd. health care services. The firm offers intravenous specialty and generic medicines, transfusion technologies, infusion therapies, parental nutrition, and medical devices. The company was founded in 1999 and is headquartered in Toronto, Canada. | Health Technology |
Biosimilars Canada
![]() Biosimilars Canada Miscellaneous Commercial ServicesCommercial Services Biosimilars Canada is a division of the Canadian Generic Pharmaceutical Association that provides leadership in educating Canadian stakeholders about the safety and efficacy of biosimilar medicines. Biosimilars Canada is based in Toronto, Canada. The member companies of Biosimilars Canada are involved in the development and marketing of biosimilar medicines. The organization advocates for policies that support the timely approval, reimbursement, market acceptance, and expanded use of biosimilar medicines. Health Canada evaluates all the information provided to confirm that the biosimilar and the reference biologic drug are similar and that there are no clinically meaningful differences in safety and efficacy between them. | Commercial Services |